Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Development of hepatic blocks using human adipose tissue-derived stem cells through three-dimensional cell printing techniques.

Lee JS., Yoon H., Yoon D., Kim GH., Yang HT., Chun W.

Laboratory Study on Scar, published in J Mater Chem B (2017) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
J Mater Chem B (2017)
Country
England
Reported sample size
—
Source database
PubMed
PMID
32263887
DOI
10.1039/c6tb03055f
Citations
9

Abstract (original English)

Currently, most acute liver diseases are treated through liver transplantation. However, transplantation is limited by organ donor scarcity and immune rejection response. Moreover, only three types of commercial bio-artificial livers are available, and these have marginal effects on survival rates. Therefore, tissue regenerative medicine using stem cells has been developed to solve such unmet medical needs. In this study, we attempted to differentiate human adipose stem cells (hASCs) into hepatocyte-like cells (AHLCs) and fabricate liver regenerative hepatic block scaffolds, consisting of only hASCs and AHLCs, through three-dimensional cell printing using a neutralized type I atelo collagen solution derived from porcine skin. Hepatic blocks were also treated with genipin, a natural cross-linking reagent, in order to maintain the structure and strength of collagen scaffolds, which contained hASCs and AHLCs. The hepatic blocks were then transplanted into the livers of SD rats to confirm safety and efficiency. The results showed that hASCs and AHLCs inside the hepatic blocks translocated into the portal vein of hepatic lobules in SD rats by 4 weeks after transplantation, as demonstrated by immunohistochemical staining using human nuclear-specific antibodies. Moreover, serum biochemistry, which was altered after induction of acute liver failure by dimethylnitrosamine, returned to n

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research